Carol Moreno
0000-0003-3275-0271
3 papers found
Refreshing results…
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study
Missing publications? Search for publications with a matching author name.